Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Plos One|December 17, 2009
A phosphoinositide 3-kinase/phospholipase Cgamma1 pathway regulates fibroblast growth factor-induced capillary tube formationTania Maffucci, Claudio Raimondi, Shadi Abu-Hayyeh, et al.
Pharmacological Research|January 8, 2019
Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoidsEmily Brook, John Mamo, Rachel Wong, et al.
BMC Evolutionary Biology|April 3, 2014
Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolutionRamatoulie E Janha, Archibald Worwui, Kenneth J Linton, et al.
Advances in Biological Regulation|December 10, 2017
Molecular and cellular mechanisms of chemoresistance in pancreatic cancerAleksandra Adamska, Omar Elaskalani, Aikaterini Emmanouilidi, et al.
The Journal of Cell Biology|June 2, 2005
Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migrationTania Maffucci, Frank T Cooke, Fiona M Foster, et al.
International Journal of Molecular Sciences|October 14, 2022
Precision Medicine Approaches with Metabolomics and Artificial IntelligenceElettra Barberis, Shahzaib Khoso, Antonio Sica, et al.
Journal of Neurochemistry|November 19, 2003
P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolinsJulie Jodoin, Michel Demeule, Laurence Fenart, et al.
Molecular Endocrinology (Baltimore, Md.)|May 10, 2003
Role of pleckstrin homology domain in regulating membrane targeting and metabolic function of insulin receptor substrate 3Tania Maffucci, Giorgia Razzini, Alessandra Ingrosso, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 5, 2024
Preclinical pharmacokinetics, pharmacodynamics, and toxicity of novel small-molecule GPR119 agonists to treat type-2 diabetes and obesityMohan Patil, Ilaria Casari, Dinesh Thapa, et al.
Pageof 17